Chlorphenamine Maleate API Market

The appearance of chlorpheniramine maleate is a white crystalline solid or white powder, the CAS number is 113-92-8, and the molecular formula is C20H23ClN2O4. Chlorpheniramine maleate preparations are available in tablets and injections.

Chlorphenamine maleate is active ingredient present in antihistamine drugs. It is useful for treating the common cold, flu, hay fever, allergic rhinitis, or other respiratory allergies. The usual symptoms include a runny nose, sneezing, itching, and watery eyes. What makes it stand apart is that, unlike most antihistamines, chlorpheniramine maleate is not so prone to produce drowsiness. This makes chlorpheniramine a suitable ingredient for daytime use.

Chlorphenamine Maleate API Market contains market size and forecasts of Chlorphenamine Maleate API in global, including the following market information:

Global Chlorphenamine Maleate API Market Revenue, 2018-2023, 2023-2030, ($ millions)

Global Chlorphenamine Maleate API Market Sales, 2018-2023, 2023-2030, (Tons)

Global top five Chlorphenamine Maleate API companies in 2022 (%)

The global Chlorphenamine Maleate API market was valued at 67 million in 2022 and is projected to reach US$ 110.4 million by 2030, at a CAGR of 7.4% during the forecast period 2023-2030.

The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.

Purity ?No Higher Than 98% Segment to Reach $ Million by 2030, with a % CAGR in next six years.

The global key manufacturers of Chlorphenamine Maleate API include Henan Jiushi Pharmaceutical, Supriya Lifescience, Kongo Chemical, Amar Healthcare, Keshava Organics and Auro Laboratories, etc. In 2022, the global top five players have a share approximately % in terms of revenue.

We surveyed the Chlorphenamine Maleate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Chlorphenamine Maleate API Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Chlorphenamine Maleate API Market Segment Percentages, by Type, 2022 (%)

Purity ?No Higher Than 98%

Purity ?Higher Than 98%

Global Chlorphenamine Maleate API Market, by Form, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Chlorphenamine Maleate API Market Segment Percentages, by Form, 2022 (%)

Tablets

Injection

Global Chlorphenamine Maleate API Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Tons)

Global Chlorphenamine Maleate API Market Segment Percentages, By Region and Country, 2022 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Chlorphenamine Maleate API revenues in global market, 2018-2023 (Estimated), ($ millions)

Key companies Chlorphenamine Maleate API revenues share in global market, 2022 (%)

Key companies Chlorphenamine Maleate API sales in global market, 2018-2023 (Estimated), (Tons)

Key companies Chlorphenamine Maleate API sales share in global market, 2022 (%)

Further, the report presents profiles of competitors in the market, key players include:

Henan Jiushi Pharmaceutical

Supriya Lifescience

Kongo Chemical

Amar Healthcare

Keshava Organics

Auro Laboratories